Literature DB >> 25710826

Pathways in gut-brain communication: evidence for distinct gut-to-brain and brain-to-gut syndromes.

Philip C Keightley1, Natasha A Koloski2, Nicholas J Talley3.   

Abstract

OBJECTIVE: The rich interconnectedness between gut and brain is increasingly being identified. This article reviews the evidence for brain-gut and gut-brain syndromes, particularly recent epidemiological evidence, and animal studies demonstrating bi-directionality at the formative stage of development.
METHOD: Narrative literature review with selection for relevance and quality.
RESULTS: Population surveys show a strong correlation between anxiety, depression, and functional gastrointestinal disorders, contradicting early suspicions that the high prevalence of anxiety and depression in the clinic was mainly due to neurotic health seeking behaviour. Five and 12 year follow-up shows that psychological distress can predict later onset of a functional gastrointestinal disorder and vice versa. Brain-gut pathways include the autonomic nervous system, hypothalamic-pituitary-adrenal axis including corticotrophin releasing factor directly acting on the gut. Gut-brain pathways include ascending pain pathways, cytokines including tumour necrosis factor alpha in response to bacterial translocation and inflammation, 5-hydroxytryptamine secretion by entero-endocrine cells and psychoactive chemicals of bacterial origin which may enter the blood stream, such as gamma-aminobutyric acid, fatty acids and 5-hydroxytryptamine precursors. The ability to control rodent temperament and HPA responsiveness with early modification of gastrointestinal flora, and the effects of early stress on the barrier function of the gastrointestinal tract and flora, suggests an ability of both systems to prime each other in early life for later problems. This hypothesis seems to be supported by a possible protective effect of a probiotic strain of bacteria in a model of early rat psychological trauma.
CONCLUSION: Psychological treatments are known to improve functional gastrointestinal disorders, the next wave of research may involve preventative microbiological gut based treatments for primary psychological presentations, both to treat the presenting complaint and inoculate against later functional gastrointestinal disorders. © The Royal Australian and New Zealand College of Psychiatrists 2015.

Entities:  

Keywords:  Irritable bowel syndrome; attachment; cytokines; epidemiology

Mesh:

Year:  2015        PMID: 25710826     DOI: 10.1177/0004867415569801

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  25 in total

Review 1.  A role for the serotonin reuptake transporter in the brain and intestinal features of autism spectrum disorders and developmental antidepressant exposure.

Authors:  Kara Gross Margolis
Journal:  J Chem Neuroanat       Date:  2017-02-14       Impact factor: 3.052

Review 2.  The brain-adipocyte-gut network: Linking obesity and depression subtypes.

Authors:  Carla M Patist; Nicolas J C Stapelberg; Eugene F Du Toit; John P Headrick
Journal:  Cogn Affect Behav Neurosci       Date:  2018-12       Impact factor: 3.282

3.  Differences in Alpha Diversity of Gut Microbiota in Neurological Diseases.

Authors:  Zhuoxin Li; Jie Zhou; Hao Liang; Li Ye; Liuyan Lan; Fang Lu; Qing Wang; Ting Lei; Xiping Yang; Ping Cui; Jiegang Huang
Journal:  Front Neurosci       Date:  2022-06-28       Impact factor: 5.152

Review 4.  Magnesium Orotate and the Microbiome-Gut-Brain Axis Modulation: New Approaches in Psychological Comorbidities of Gastrointestinal Functional Disorders.

Authors:  Cristina Schiopu; Gabriela Ștefănescu; Smaranda Diaconescu; Gheoghe G Bălan; Nicoleta Gimiga; Elena Rusu; Cosmin Alec Moldovan; Bogdan Popa; Elena Tataranu; Andrei Vasile Olteanu; Alexandra Boloș; Cristinel Ștefănescu
Journal:  Nutrients       Date:  2022-04-09       Impact factor: 6.706

Review 5.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

Review 6.  The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease.

Authors:  Gerwyn Morris; Michael Berk; Andre Carvalho; Javier R Caso; Yolanda Sanz; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

7.  Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis.

Authors:  Heidi S Donovan; Teresa L Hagan; Grace B Campbell; Michelle M Boisen; Leah M Rosenblum; Robert P Edwards; Dana H Bovbjerg; Charles C Horn
Journal:  Support Care Cancer       Date:  2016-01-08       Impact factor: 3.603

8.  Investigation of body image as a mediator of the effects of bowel and GI symptoms on psychological distress in female survivors of rectal and anal cancer.

Authors:  Catherine Benedict; Vivian M Rodriguez; Jeanne Carter; Larissa Temple; Christian Nelson; Katherine DuHamel
Journal:  Support Care Cancer       Date:  2015-10-07       Impact factor: 3.603

9.  Comparative efficacy and acceptability of psychotropic drugs for functional dyspepsia in adults: A systematic review and network meta-analysis.

Authors:  Wan Zhou; Xia Li; Yin Huang; Xiaoxiao Xu; Yan Liu; Jiayan Wang; Gang Nie; Dongdong Zhou
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 10.  Early interventions in risk groups for schizophrenia: what are we waiting for?

Authors:  Iris E Sommer; Carrie E Bearden; Edwin van Dellen; Elemi J Breetvelt; Sasja N Duijff; Kim Maijer; Therese van Amelsvoort; Lieuwe de Haan; Raquel E Gur; Celso Arango; Covadonga M Díaz-Caneja; Christiaan H Vinkers; Jacob As Vorstman
Journal:  NPJ Schizophr       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.